The 2022 American Society for Metabolic and Bariatric Surgery and International Federation for Surgery and Other Therapies for Obesity guidelines 29 recommend metabolic-bariatric surgery for patients with MASLD or MASH whose body mass index is 30 kg/m 2 or higher who do not achieve substantial weight loss with nonsurgical methods
Overall, the GLP-1 group had a significantly better survival rate and a lower risk of AFib
Originally developed to tackle the escalating epidemic of diabetes, this versatile drug has transcended its primary purpose to offer hope and healing to individuals grappling with obesity, chronic pain, and mental health challenges
Ethics declarations Conflict of interest There is no conflict of interest
[DOI] [PMC free article] [PubMed] [Google Scholar] [11].Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, et al
Store refrigerated at 2 to 8 degrees Celsius